Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1 S,2 S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents
Year: 2007
Type: article
Authors: Tung M. Fong, Xiao-Ming Guan, Donald J. Marsh, Chun-Pyn Shen, D. Sloan Stribling, Kim M. Rosko, Julie Lao, Hong Yu, Yue Feng, Jing C. Xiao, Lex H.T. Van der Ploeg, Mark T. Goulet, Williams K. Hagmann, Linus S. Lin, Thomas J. Lanza, James P. Jewell, Ping Liu, Shrenik K. Shah, Hongbo Qi, Xinchun Tong, Junying Wang, Suoyu S. Xu, Barbara Francis, Alison M. Strack, D. Euan MacIntyre, Lauren P. Shearman
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1922019985